Erbil
Rethinking dissections: How drug-coated balloons may turn risk into an opportunity
Interventional cardiologists often fear the occurrence of dissections after percutaneous coronar...
Invasive strategy does not reduce risk of cardiovascular death or non-fatal MI in older NSTEMI patients
A trial comparing an invasive and a conservative strategy to treat patients over the age of 75 y...
DCB is an effective option for PCI in patients with diabetes
Diabetes is one of the strongest risk factors for coronary disease, Pedro Lemos (Hospital Israel...
New evidence suggests fasting not needed before cardiac catheterisation procedures
A randomised trial testing whether the removal of fasting requirements prior to cath lab procedu...
PCI should be standard of care in patients with coronary artery disease undergoing valve replacement
Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients ...
Robotic PCI: TESLA registry demonstrates high clinical success rate for robotic platform
Insights from the TESLA registry, an investigator-initiated real-world study of robotically-assist...
How using DCBs can “open up a new world” for PCI
Early exposure to the use of drug-coated balloons (DCBs) for percutaneous coronary intervention ...
NOTION-2 trial: What are the implications for TAVI in young, low-risk patients with bicuspid valves?
Ole De Backer (Copenhagen, Denmark) unpacks the results of the NOTION-2 study, in which investigat...
